Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice
XIANYANG, China, April 23, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products inChina, announced today that on received a notification letter from Nasdaq Listing Qualifications (...
Biostar Pharmaceuticals, Inc. Announces Plans to Launch a New eCommerce Sales Platform
XIANYANG, China, Feb. 21, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced its plans to launch a new e-c...
Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification
XIANYANG, China, Feb. 7, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products inChina for a variety of diseases and conditions, today announced that its variable inter...
Biostar Regains Compliance with NASDAQ Continued Listing Requirement
XIANYANG, China, Dec. 4, 2017 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products inChina, announced that onNovember 30, 2017, it received a letter from the NASDAQ Listing ...
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017
XIANYANG, China, Nov. 20, 2017 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products inChina for a variety of diseases and conditions, today announced its financial results ...
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017
XIANYANG, China, Nov. 15, 2017 /PRNewswire/ - Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products inChina for a variety of diseases and conditions, today announced its financial results f...
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice
XIANYANG, China, Aug. 28, 2017 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products inChina, announced today that on August 22, 2017 it received a notification letter from Nasdaq Listin...
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2017
XIANYANG, China, May 19, 2017 /PRNewswire/ - Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products inChina for a variety of diseases and conditions, today announced its financial results fo...
